155 related articles for article (PubMed ID: 22974970)
1. Avascular tumour growth dynamics and the constraints of protein binding for drug transportation.
Kazmi N; Hossain MA; Phillips RM; Al-Mamun MA; Bass R
J Theor Biol; 2012 Nov; 313():142-52. PubMed ID: 22974970
[TBL] [Abstract][Full Text] [Related]
2. A hybrid cellular automaton model of solid tumor growth and bioreductive drug transport.
Kazmi N; Hossain MA; Phillips RM
IEEE/ACM Trans Comput Biol Bioinform; 2012; 9(6):1595-606. PubMed ID: 23221082
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
[TBL] [Abstract][Full Text] [Related]
4. Measurement of delivery and metabolism of tirapazamine to tumour tissue using the multilayered cell culture model.
Kyle AH; Minchinton AI
Cancer Chemother Pharmacol; 1999; 43(3):213-20. PubMed ID: 9923551
[TBL] [Abstract][Full Text] [Related]
5. Simulating growth dynamics and radiation response of avascular tumour spheroids-model validation in the case of an EMT6/Ro multicellular spheroid.
Zacharaki EI; Stamatakos GS; Nikita KS; Uzunoglu NK
Comput Methods Programs Biomed; 2004 Dec; 76(3):193-206. PubMed ID: 15501506
[TBL] [Abstract][Full Text] [Related]
6. Multicellular resistance to tirapazamine is due to restricted extravascular transport: a pharmacokinetic/pharmacodynamic study in HT29 multicellular layer cultures.
Hicks KO; Pruijn FB; Sturman JR; Denny WA; Wilson WR
Cancer Res; 2003 Sep; 63(18):5970-7. PubMed ID: 14522924
[TBL] [Abstract][Full Text] [Related]
7. A quantitative cellular automaton model of in vitro multicellular spheroid tumour growth.
Piotrowska MJ; Angus SD
J Theor Biol; 2009 May; 258(2):165-78. PubMed ID: 19248794
[TBL] [Abstract][Full Text] [Related]
8. A hybrid computational model for the effects of maspin on cancer cell dynamics.
Al-Mamun MA; Brown LJ; Hossain MA; Fall C; Wagstaff L; Bass R
J Theor Biol; 2013 Nov; 337():150-60. PubMed ID: 23988797
[TBL] [Abstract][Full Text] [Related]
9. Hanging-drop multicellular spheroids as a model of tumour angiogenesis.
Timmins NE; Dietmair S; Nielsen LK
Angiogenesis; 2004; 7(2):97-103. PubMed ID: 15516830
[TBL] [Abstract][Full Text] [Related]
10. Continuum versus discrete model: a comparison for multicellular tumour spheroids.
Schaller G; Meyer-Hermann M
Philos Trans A Math Phys Eng Sci; 2006 Jun; 364(1843):1443-64. PubMed ID: 16766354
[TBL] [Abstract][Full Text] [Related]
11. Implication of necrosis-linked p53 aggregation in acquired apoptotic resistance to 5-FU in MCF-7 multicellular tumour spheroids.
Lee SY; Jeong EK; Jeon HM; Kim CH; Kang HS
Oncol Rep; 2010 Jul; 24(1):73-9. PubMed ID: 20514446
[TBL] [Abstract][Full Text] [Related]
12. The role of cell-cell interactions in a two-phase model for avascular tumour growth.
Breward CJ; Byrne HM; Lewis CE
J Math Biol; 2002 Aug; 45(2):125-52. PubMed ID: 12181602
[TBL] [Abstract][Full Text] [Related]
13. Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts.
Huxham LA; Kyle AH; Baker JH; McNicol KL; Minchinton AI
Radiother Oncol; 2006 Feb; 78(2):138-45. PubMed ID: 16455148
[TBL] [Abstract][Full Text] [Related]
14. An agent-based model for drug-radiation interactions in the tumour microenvironment: Hypoxia-activated prodrug SN30000 in multicellular tumour spheroids.
Mao X; McManaway S; Jaiswal JK; Patel PB; Wilson WR; Hicks KO; Bogle G
PLoS Comput Biol; 2018 Oct; 14(10):e1006469. PubMed ID: 30356233
[TBL] [Abstract][Full Text] [Related]
15. Growth of confined cancer spheroids: a combined experimental and mathematical modelling approach.
Loessner D; Flegg JA; Byrne HM; Clements JA; Hutmacher DW
Integr Biol (Camb); 2013 Mar; 5(3):597-605. PubMed ID: 23388834
[TBL] [Abstract][Full Text] [Related]
16. Oxygen dependence and extravascular transport of hypoxia-activated prodrugs: comparison of the dinitrobenzamide mustard PR-104A and tirapazamine.
Hicks KO; Myint H; Patterson AV; Pruijn FB; Siim BG; Patel K; Wilson WR
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):560-71. PubMed ID: 17869669
[TBL] [Abstract][Full Text] [Related]
17. On the surviving fraction in irradiated multicellular tumour spheroids: calculation of overall radiosensitivity parameters, influence of hypoxia and volume effects.
Horas JA; Olguin OR; Rizzotto MG
Phys Med Biol; 2005 Apr; 50(8):1689-701. PubMed ID: 15815090
[TBL] [Abstract][Full Text] [Related]
18. Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: biological insights from a hybrid multiscale cellular automaton model.
Powathil GG; Gordon KE; Hill LA; Chaplain MA
J Theor Biol; 2012 Sep; 308():1-19. PubMed ID: 22659352
[TBL] [Abstract][Full Text] [Related]
19. Modelling the cell cycle and cell movement in multicellular tumour spheroids.
Tindall MJ; Please CP
Bull Math Biol; 2007 May; 69(4):1147-65. PubMed ID: 17372784
[TBL] [Abstract][Full Text] [Related]
20. A single-cell-based model of tumor growth in vitro: monolayers and spheroids.
Drasdo D; Höhme S
Phys Biol; 2005 Jul; 2(3):133-47. PubMed ID: 16224119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
